Assets in USD of Xilio Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Xilio Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2025.
  • Xilio Therapeutics, Inc. Assets for the quarter ending September 30, 2025 was $134M, a 79.1% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)

Xilio Therapeutics, Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $134M +$59M +79.1% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $134M +$43.9M +48.9% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $104M +$21.1M +25.6% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $71.1M +$10.1M +16.7% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $74.7M -$3.18M -4.09% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $89.9M -$2.49M -2.69% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $82.6M -$28.9M -25.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $60.9M -$78.2M -56.2% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $77.8M -$79.6M -50.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $92.4M -$85.8M -48.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $112M -$84.8M -43.2% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $139M -$78.9M -36.2% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $157M +$36.7M +30.4% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $178M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $196M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $218M +$182M +500% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $121M Sep 30, 2021 10-Q 2021-12-02
Q4 2020 $36.3M Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.